Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.
Cosmo Pharmaceuticals has enrolled about 850 out of 1400 patients for their phase3clinicaltrials of clascoterone (Breezula) and claims to be on schedule. The conversation is about hair loss treatments.
A user shared a six-month update on hair improvement using Pyrilutamide and Minoxidil, noting significant hair regrowth and strength. Some participants questioned the legitimacy of the results and the source of Pyrilutamide.
The conversation discusses Breezula, a hair loss treatment, and its Phase3clinicaltrial recruitment at 50 locations. Specific treatments mentioned include Minoxidil, Finasteride, and RU58841.